Chris Lewis
Stock Analyst at Roth Capital
(3.03)
# 1,248
Out of 5,154 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $8.69 | -53.97% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $98.72 | -83.79% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $28.55 | -49.21% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.50 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $1.24 | +1,512.90% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $8.69
Upside: -53.97%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $98.72
Upside: -83.79%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $28.55
Upside: -49.21%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $103.50
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $1.24
Upside: +1,512.90%